| Breakdown | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.32B | 6.20B | 5.85B | 5.07B | 4.43B |
| Gross Profit | 3.21B | 1.88B | 371.13M | 254.84M | 239.01M |
| EBITDA | 565.79M | 614.79M | 553.39M | 412.88M | 363.64M |
| Net Income | 243.63M | 304.43M | 224.71M | 165.12M | 140.69M |
Balance Sheet | |||||
| Total Assets | 4.25B | 3.90B | 3.72B | 3.26B | 2.97B |
| Cash, Cash Equivalents and Short-Term Investments | 450.14M | 903.56M | 924.98M | 661.79M | 588.20M |
| Total Debt | 602.40M | 422.76M | 544.36M | 480.80M | 465.11M |
| Total Liabilities | 1.95B | 1.77B | 1.83B | 1.55B | 1.43B |
| Stockholders Equity | 2.29B | 2.12B | 1.88B | 1.71B | 1.53B |
Cash Flow | |||||
| Free Cash Flow | 112.91M | 197.26M | 248.47M | 76.23M | 113.08M |
| Operating Cash Flow | 436.85M | 490.73M | 509.92M | 327.21M | 330.57M |
| Investing Cash Flow | -534.30M | -312.37M | -270.08M | -262.25M | -213.74M |
| Financing Cash Flow | 119.11M | -169.09M | -126.23M | -36.16M | -26.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €3.52B | 5.69 | 11.24% | 1.76% | 514.19% | -7.82% | |
72 Outperform | €809.19M | 5.57 | 5.22% | 2.73% | 5.30% | -14.66% | |
64 Neutral | €45.19B | 27.07 | 11.27% | 2.80% | 0.54% | 83.09% | |
60 Neutral | €100.30M | 4.64 | ― | 5.18% | 0.17% | -97.54% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €274.94M | 1.52 | 3.16% | 1.98% | -7.08% | 90.42% |